Global RNAi for Therapeutic Market Study By Segment (siRNA, miRNA, shRNA), By Market (Cancer, CardiovascularmiRNA, HBV), By Company (Alnylam Pharmaceuticals, Arrowhead, Dicerna Pharmaceuticals) 2015-2025
Report ID: 2368 | Sep 2018 | No. of Pages: 74
|
Snapshot
RNA interference (RNAi) is a biological process in which RNA molecules inhibit gene expression, typically by causing the destruction of specific mRNA molecules. Historically, it was known by other names, including co-suppression, post-transcriptional gene silencing (PTGS), and quelling. Only after these apparently unrelated processes were fully understood did it become clear that they all described the RNAi phenomenon. RNAi is now known as precise, efficient, stable and better than antisense technology for gene suppression.
The global RNAi for Therapeutic market will reach xxx Million USD in 2018 and with a CAGR if xx% between 2019-2025.
Product Type Coverage (Market Size & Forecast, Major Company of Product Type etc.):
siRNA
miRNA
shRNA
Demand Coverage (Market Size & Forecast, Consumer Distribution):
Cancer
Cardiovascular
HBV
Others
Company Coverage (Sales data, Main Products & Services etc.):
Alnylam Pharmaceuticals
Arrowhead
Dicerna Pharmaceuticals
Mirna Therapeutics
Quark Pharmaceuticals
RXi Pharmaceuticals
miRagen Therapeutics
Gradalis
Sirnaomics
Major Region Market
North America
Europe
Asia-Pacific
South America
Middle East & Africa
RNA interference (RNAi) is a biological process in which RNA molecules inhibit gene expression, typically by causing the destruction of specific mRNA molecules. Historically, it was known by other names, including co-suppression, post-transcriptional gene silencing (PTGS), and quelling. Only after these apparently unrelated processes were fully understood did it become clear that they all described the RNAi phenomenon. RNAi is now known as precise, efficient, stable and better than antisense technology for gene suppression.
The global RNAi for Therapeutic market will reach xxx Million USD in 2018 and with a CAGR if xx% between 2019-2025.
Product Type Coverage (Market Size & Forecast, Major Company of Product Type etc.):
siRNA
miRNA
shRNA
Demand Coverage (Market Size & Forecast, Consumer Distribution):
Cancer
Cardiovascular
HBV
Others
Company Coverage (Sales data, Main Products & Services etc.):
Alnylam Pharmaceuticals
Arrowhead
Dicerna Pharmaceuticals
Mirna Therapeutics
Quark Pharmaceuticals
RXi Pharmaceuticals
miRagen Therapeutics
Gradalis
Sirnaomics
Major Region Market
North America
Europe
Asia-Pacific
South America
Middle East & Africa
Table of Content
1 Industry Overview
1.1 RNAi for Therapeutic Industry
1.1.1 Overview
1.1.2 Products of Major Companies
1.2 Market Segment
1.2.1 Industry Chain
1.2.2 Consumer Distribution
1.3 Price & Cost Overview
2 RNAi for Therapeutic Market by Type
2.1 By Type
2.1.1 siRNA
2.1.2 miRNA
2.1.3 shRNA
2.2 Market Size by Type
2.3 Market Forecast by Type
3 Global Market Demand
3.1 Segment Overview
3.1.1 Cancer
3.1.2 Cardiovascular
3.1.3 HBV
3.1.4 Others
3.2 Market Size by Demand
3.3 Market Forecast by Demand
4 Major Region Market
4.1 Global Market Overview
4.1.1 Market Size & Growth
4.1.2 Market Forecast
4.2 Major Region
4.2.1 Market Size & Growth
4.2.2 Market Forecast
5 Major Companies List
5.1 Alnylam Pharmaceuticals (Company Profile, Sales Data etc.)
5.2 Arrowhead (Company Profile, Sales Data etc.)
5.3 Dicerna Pharmaceuticals (Company Profile, Sales Data etc.)
5.4 Mirna Therapeutics (Company Profile, Sales Data etc.)
5.5 Quark Pharmaceuticals (Company Profile, Sales Data etc.)
5.6 RXi Pharmaceuticals (Company Profile, Sales Data etc.)
5.7 miRagen Therapeutics (Company Profile, Sales Data etc.)
5.8 Gradalis (Company Profile, Sales Data etc.)
5.9 Sirnaomics (Company Profile, Sales Data etc.)
6 ConclusionTable Global RNAi for Therapeutic Market 2015-2018, by Type, in USD Million
Table Global RNAi for Therapeutic Market 2015-2018, by Type, in Volume
Table Global RNAi for Therapeutic Market Forecast 2019-2025, by Type, in USD Million
Table Global RNAi for Therapeutic Market Forecast 2019-2025, by Type, in Volume
Table Alnylam Pharmaceuticals Overview List
Table RNAi for Therapeutic Business Operation of Alnylam Pharmaceuticals (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Arrowhead Overview List
Table RNAi for Therapeutic Business Operation of Arrowhead (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Dicerna Pharmaceuticals Overview List
Table RNAi for Therapeutic Business Operation of Dicerna Pharmaceuticals (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Mirna Therapeutics Overview List
Table RNAi for Therapeutic Business Operation of Mirna Therapeutics (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Quark Pharmaceuticals Overview List
Table RNAi for Therapeutic Business Operation of Quark Pharmaceuticals (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table RXi Pharmaceuticals Overview List
Table RNAi for Therapeutic Business Operation of RXi Pharmaceuticals (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table miRagen Therapeutics Overview List
Table RNAi for Therapeutic Business Operation of miRagen Therapeutics (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Gradalis Overview List
Table RNAi for Therapeutic Business Operation of Gradalis (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Sirnaomics Overview List
Table RNAi for Therapeutic Business Operation of Sirnaomics (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Figure Global RNAi for Therapeutic Market Growth 2015-2018, by Type, in USD Million
Figure Global RNAi for Therapeutic Market Growth 2015-2018, by Type, in Volume
1 Industry Overview
1.1 RNAi for Therapeutic Industry
1.1.1 Overview
1.1.2 Products of Major Companies
1.2 Market Segment
1.2.1 Industry Chain
1.2.2 Consumer Distribution
1.3 Price & Cost Overview
2 RNAi for Therapeutic Market by Type
2.1 By Type
2.1.1 siRNA
2.1.2 miRNA
2.1.3 shRNA
2.2 Market Size by Type
2.3 Market Forecast by Type
3 Global Market Demand
3.1 Segment Overview
3.1.1 Cancer
3.1.2 Cardiovascular
3.1.3 HBV
3.1.4 Others
3.2 Market Size by Demand
3.3 Market Forecast by Demand
4 Major Region Market
4.1 Global Market Overview
4.1.1 Market Size & Growth
4.1.2 Market Forecast
4.2 Major Region
4.2.1 Market Size & Growth
4.2.2 Market Forecast
5 Major Companies List
5.1 Alnylam Pharmaceuticals (Company Profile, Sales Data etc.)
5.2 Arrowhead (Company Profile, Sales Data etc.)
5.3 Dicerna Pharmaceuticals (Company Profile, Sales Data etc.)
5.4 Mirna Therapeutics (Company Profile, Sales Data etc.)
5.5 Quark Pharmaceuticals (Company Profile, Sales Data etc.)
5.6 RXi Pharmaceuticals (Company Profile, Sales Data etc.)
5.7 miRagen Therapeutics (Company Profile, Sales Data etc.)
5.8 Gradalis (Company Profile, Sales Data etc.)
5.9 Sirnaomics (Company Profile, Sales Data etc.)
6 ConclusionTable Global RNAi for Therapeutic Market 2015-2018, by Type, in USD Million
Table Global RNAi for Therapeutic Market 2015-2018, by Type, in Volume
Table Global RNAi for Therapeutic Market Forecast 2019-2025, by Type, in USD Million
Table Global RNAi for Therapeutic Market Forecast 2019-2025, by Type, in Volume
Table Alnylam Pharmaceuticals Overview List
Table RNAi for Therapeutic Business Operation of Alnylam Pharmaceuticals (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Arrowhead Overview List
Table RNAi for Therapeutic Business Operation of Arrowhead (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Dicerna Pharmaceuticals Overview List
Table RNAi for Therapeutic Business Operation of Dicerna Pharmaceuticals (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Mirna Therapeutics Overview List
Table RNAi for Therapeutic Business Operation of Mirna Therapeutics (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Quark Pharmaceuticals Overview List
Table RNAi for Therapeutic Business Operation of Quark Pharmaceuticals (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table RXi Pharmaceuticals Overview List
Table RNAi for Therapeutic Business Operation of RXi Pharmaceuticals (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table miRagen Therapeutics Overview List
Table RNAi for Therapeutic Business Operation of miRagen Therapeutics (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Gradalis Overview List
Table RNAi for Therapeutic Business Operation of Gradalis (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Sirnaomics Overview List
Table RNAi for Therapeutic Business Operation of Sirnaomics (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Figure Global RNAi for Therapeutic Market Growth 2015-2018, by Type, in USD Million
Figure Global RNAi for Therapeutic Market Growth 2015-2018, by Type, in Volume
1. This report provides in depth analysis for changing competitive dynamics and keeps you ahead of competitors
2. It provides a forward looking perspective on different factors driving or restraining market growth
3. It provides a ten-year forecast assessed on the basis of how the market is expected to grow
4. It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of various market segments
Connect With Us
+1-707-633-0404
sales@search4research.com
Related reports
|
|
ECG Management Systems Market Growth Opportunities to 2030 - North America, Europe, Asia-Pacific, South America, Middle East and Africa
Publication Month: May 2024 | No. of Pages: 120
|
$4750Buy Now |
|
|
Adult Day Care Services Market Growth Opportunities to 2030 - North America, Europe, Asia-Pacific, South America, Middle East and Africa
Publication Month: May 2024 | No. of Pages: 120
|
$4750Buy Now |
|
|
Virtual Microscopy Market Growth Opportunities to 2030 - North America, Europe, Asia-Pacific, South America, Middle East and Africa
Publication Month: May 2024 | No. of Pages: 120
|
$4750Buy Now |
|
|
Teledentistry Market Growth Opportunities to 2030 - North America, Europe, Asia-Pacific, South America, Middle East and Africa
Publication Month: May 2024 | No. of Pages: 120
|
$4750Buy Now |
|
|
Medical Second Opinion Market Growth Opportunities to 2030 - North America, Europe, Asia-Pacific, South America, Middle East and Africa
Publication Month: May 2024 | No. of Pages: 120
|
$4750Buy Now |